Press Room
There are 3 item(s) tagged with the keyword "Novo Nordisk".
Displaying: 1 - 3 of 3
1. JDRF Partner ViaCyte Announces Key Project Milestone
JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes
2. Novo Nordisk Commits $5 Million Grant Supporting JDRF Outreach Initiative
To address the need for education on how patients with type 1 diabetes (T1D) can pursue physical activity safely, Novo Nordisk has committed to a three-year, $5 million grant in support of a new JDRF Outreach initiative titled “T1D Performance in Exercise and Know...
3. EFSD, JDRF and Novo Nordisk renew partnership for type 1 diabetes research in Europe
Stockholm, Sweden, Sept. 22, 2010 --- The European Foundation for the Study of Diabetes (EFSD), the Juvenile Diabetes Research Foundation (JDRF) and Novo Nordisk A/S announced today the renewal of their partnership to support type 1 diabetes research in Europe. The announcement was made at the Europ...
Displaying: 1 - 3 of 3
(3).png)
